161 related articles for article (PubMed ID: 20517105)
21. Augmentation of the malar area with polyacrylamide hydrogel: experience with more than 1300 patients.
Reda-Lari A
Aesthet Surg J; 2008; 28(2):131-8. PubMed ID: 19083517
[TBL] [Abstract][Full Text] [Related]
22. Use of Aquamid as a filler for facial rejuvenation in orientals.
Yagi Y; Kato K; Murakami D; Misaki K; Ota M; Kataoka J; Yukawa N
J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):1245-9. PubMed ID: 19303835
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
Jansen DA; Graivier MH
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
[TBL] [Abstract][Full Text] [Related]
24. 5-year study of a polyacrylamide hydrogel-based filler for rehabilitation of HIV-related facial lipoatrophy.
Rauso R
Aesthet Surg J; 2015 Nov; 35(8):1021-9. PubMed ID: 25953480
[TBL] [Abstract][Full Text] [Related]
25. Discussion of: Complications of polyacrylamide hydrogel (PAAG) injection in facial augmentation. JPRAS 2010;63(1):e9-12.
Stark GB
J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):721. PubMed ID: 19540183
[No Abstract] [Full Text] [Related]
26. Patient-preferred sites of restylane injection in periocular and facial soft-tissue augmentation.
Morris CL; Stinnett SS; Woodward JA
Ophthalmic Plast Reconstr Surg; 2008; 24(2):117-21. PubMed ID: 18356716
[TBL] [Abstract][Full Text] [Related]
27. [Cosmetic soft-tissue augmentation treatment].
Thyssen JP; Christensen LH; Zachariae CO
Ugeskr Laeger; 2007 Jun; 169(23):2198-201. PubMed ID: 17592685
[TBL] [Abstract][Full Text] [Related]
28. Delayed-onset complications of facial soft tissue augmentation with permanent fillers in 85 patients.
Kadouch JA; Kadouch DJ; Fortuin S; van Rozelaar L; Karim RB; Hoekzema R
Dermatol Surg; 2013 Oct; 39(10):1474-85. PubMed ID: 24090257
[TBL] [Abstract][Full Text] [Related]
29. Removal of the permanent filler polyacrylamide hydrogel (aquamid) is possible and easy even after several years.
Wolter TP; Pallua N
Plast Reconstr Surg; 2010 Sep; 126(3):138e-139e. PubMed ID: 20811192
[No Abstract] [Full Text] [Related]
30. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
Sadick NS; Katz BE; Roy D
Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
[TBL] [Abstract][Full Text] [Related]
31. Emerging permanent filler technologies: focus on Aquamid.
Yamauchi PS
Clin Cosmet Investig Dermatol; 2014; 7():261-6. PubMed ID: 25336982
[TBL] [Abstract][Full Text] [Related]
32. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
Silvers SL; Eviatar JA; Echavez MI; Pappas AL
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
[TBL] [Abstract][Full Text] [Related]
33. Surgery for foreign body reactions due to injectable fillers.
Wolfram D; Tzankov A; Piza-Katzer H
Dermatology; 2006; 213(4):300-4. PubMed ID: 17135735
[TBL] [Abstract][Full Text] [Related]
34. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.
Rauso R; Curinga G; Santillo V; Corvo G; Tartaro G
J Craniofac Surg; 2011 Sep; 22(5):1684-8. PubMed ID: 21959413
[TBL] [Abstract][Full Text] [Related]
35. Polyacrylamide soft tissue filler nodule mimicking a mucoepidermoid carcinoma.
Karagozoglu KH; van der Waal I
Int J Oral Maxillofac Surg; 2008 Jun; 37(6):578-80. PubMed ID: 18313268
[TBL] [Abstract][Full Text] [Related]
36. Effect of prophylactic antibiotics on polyacrylamide gel safety in facial augmentation.
Nygart JF; Nygart VA; Borggren M; Tvede M
J Drugs Dermatol; 2014 May; 13(5):571-3. PubMed ID: 24809880
[TBL] [Abstract][Full Text] [Related]
37. Unacceptable results with an accepted soft tissue filler: polyacrylamide hydrogel.
Manafi A; Emami AH; Pooli AH; Habibi M; Saidian L
Aesthetic Plast Surg; 2010 Aug; 34(4):413-22. PubMed ID: 19452201
[TBL] [Abstract][Full Text] [Related]
38. 12-Month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel soft-tissue filler.
Narins RS; Coleman WP; Rohrich R; Monheit G; Glogau R; Brandt F; Bruce S; Colen L; Dayan S; Jackson I; Maas C; Rivkin A; Sclafani A; Spivak JC
Dermatol Surg; 2010 Nov; 36 Suppl 3():1819-29. PubMed ID: 20969659
[TBL] [Abstract][Full Text] [Related]
39. Visual field defect after facial rejuvenation with botulinum toxin type A and polyacrylamide hydrogel injection.
Chen YH; Tsai YJ; Chao AN; Huang YS; Kao LY
Plast Reconstr Surg; 2010 Nov; 126(5):249e-250e. PubMed ID: 21042073
[No Abstract] [Full Text] [Related]
40. Prospective multicenter study for evaluation of safety, efficacy, and esthetic results of cross-linked polyacrylamide hydrogel in 81 patients.
Wolters M; Lampe H
Dermatol Surg; 2009 Feb; 35 Suppl 1():338-43. PubMed ID: 19207323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
